China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche''s Genentech
After penning a deal with Orion in May for a non-opioid pain drug, Jemincare is back at the licensing deal table, inking a development and sales deal with Roche Holdings AG''s (OTC: RHHBY ) Genentech unit for a prostate cancer drug. In return, Genentech will get a worldwide license to develop the program, known as … Full story available on Benzinga.com
China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche''s Genentech
After penning a deal with Orion in May for a non-opioid pain drug, Jemincare is back at the licensing deal table, inking a development and sales deal with Roche Holdings AG''s (OTC: RHHBY ) Genentech unit for a prostate cancer drug. In return, Genentech will get a worldwide license to develop the program, known as … Full story available on Benzinga.com